Insights

Key Partnerships Y-mAbs Therapeutics is seeking partnerships and collaborations to enhance their pipeline of antibody-based oncology products, presenting a sales opportunity for companies with complementary technologies or research.

Expansion of Product Line With a focus on addressing unmet medical needs in pediatric and adult oncology, Y-mAbs is actively expanding its product pipeline, creating potential sales avenues for suppliers of raw materials, manufacturing equipment, and clinical trial services.

Strategic Acquisitions Given Y-mAbs' growth trajectory and mission to lead in oncology therapeutics, the company may be open to strategic acquisitions of smaller biotech firms, offering a sales opportunity for businesses looking to be acquired or provide supportive services post-acquisition.

Revenue Growth Potential Y-mAbs' position as a commercial-stage biopharmaceutical company with FDA-approved products indicates revenue growth potential, making it an attractive target for sales of salesforce optimization tools, market analytics, and CRM solutions to support expanding sales teams.

Competitive Positioning As Y-mAbs competes in the biotechnology research sector with a focus on cancer treatments, there is a sales opportunity for consultants offering competitive analysis services, market intelligence tools, and marketing strategies tailored to differentiate Y-mAbs in the market.

Y-mAbs Therapeutics, Inc. Tech Stack

Y-mAbs Therapeutics, Inc. uses 8 technology products and services including Akamai, Cloudflare CDN, WordPress, and more. Explore Y-mAbs Therapeutics, Inc.'s tech stack below.

  • Akamai
    Content Delivery Network
  • Cloudflare CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • Shopify
    E-commerce
  • React
    Javascript Frameworks
  • Open Graph
    Miscellaneous
  • Module Federation
    Miscellaneous
  • HSTS
    Security

Media & News

Y-mAbs Therapeutics, Inc.'s Email Address Formats

Y-mAbs Therapeutics, Inc. uses at least 1 format(s):
Y-mAbs Therapeutics, Inc. Email FormatsExamplePercentage
FL@ymabs.comJD@ymabs.com
37%
FLast@ymabs.comJDoe@ymabs.com
30%
FirstLast@ymabs.comJohnDoe@ymabs.com
20%
Last@ymabs.comDoe@ymabs.com
13%

Frequently Asked Questions

Where is Y-mAbs Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc.'s main headquarters is located at 230 Park Avenue 3350 New York, NY 10169 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Y-mAbs Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Y-mAbs Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Y-mAbs Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc. is a publicly traded company; the company's stock symbol is YMAB.

What is Y-mAbs Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc.'s official website is ymabs.com and has social profiles on LinkedIn.

How much revenue does Y-mAbs Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Y-mAbs Therapeutics, Inc.'s annual revenue reached $35M.

What is Y-mAbs Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Y-mAbs Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Y-mAbs Therapeutics, Inc. has approximately 120 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: V. R.Chief Development Officer, Y-Mabs Therapeutics, Inc: N. L.Chief Financial Officer: P. P.. Explore Y-mAbs Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Y-mAbs Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Y-mAbs Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc.'s tech stack includes AkamaiCloudflare CDNWordPressShopifyReactOpen GraphModule FederationHSTS.

What is Y-mAbs Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc.'s email format typically follows the pattern of . Find more Y-mAbs Therapeutics, Inc. email formats with LeadIQ.

How much funding has Y-mAbs Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, Y-mAbs Therapeutics, Inc. has raised $115M in funding. The last funding round occurred on Feb 17, 2021 for $115M.

When was Y-mAbs Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc. was founded in 2015.
Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc.

Biotechnology ResearchNew York, United States51-200 Employees

Y-mAbs is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. We have a broad and advanced product pipeline, including pivotal-stage product candidates against a range of targets.

Our mission is to become the world leader in developing better and safer antibody-based oncology products addressing clear unmet pediatric and adult medical needs. With the right partnerships and collaborations, we envision changing the course of cancer care and its outcomes.

Section iconCompany Overview

Headquarters
230 Park Avenue 3350 New York, NY 10169 US
Phone number
Website
ymabs.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
YMAB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $115M

    Y-mAbs Therapeutics, Inc. has raised a total of $115M of funding over 4 rounds. Their latest funding round was raised on Feb 17, 2021 in the amount of $115M.

  • $10M$50M

    Y-mAbs Therapeutics, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $115M

    Y-mAbs Therapeutics, Inc. has raised a total of $115M of funding over 4 rounds. Their latest funding round was raised on Feb 17, 2021 in the amount of $115M.

  • $10M$50M

    Y-mAbs Therapeutics, Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.